Radiation and concomitante chemotherapy after surgery for breast cancer;Irradiation et chimiothérapie concomitante après chirurgie pour cancer du sein

Cancer/Radiotherapie

Volumn 8, Issue 1, 2004, Pages 39-47

  Calais, G ^a  

^a CHU BRETONNEAU   (France)

Author keywords

Breast cancer; Concomitant chemotherapy; Radiation

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOXANTRONE; PACLITAXEL;

ALOPECIA; ARTICLE; BLOOD TOXICITY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; CHRONOSEQUENCE; CHRONOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DYSPHAGIA; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; INFECTION; LUNG TOXICITY; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PILOT STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN NECROSIS; SKIN TOXICITY; TREATMENT OUTCOME;

EID: 1242293166     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2003.10.010     Document Type: Short Survey

References (44)

1. Bellon J.R., Lindsley K.L., Ellis G.K. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer. Int J Radiat Oncol Biol Phys. 48:2000;393-397.
2. Bennet J.M., Muss H.B., Doroschow J.H., Wolff S., Krementz E.T., Cartwright K., et al. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide and fluorouracil with doxorubicin cyclophosphamide and fluorouracil in the therapy of metastatic breast carcinoma. J Clin Oncol. 6:1988;1611-1620.
3. Broger J., Keijser A. Conservative breast cancer treatment: analysis of cosmetic results and the role of concomitant adjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 13:1987;1173-1177.
4. Bucholz T.A., Griffin T., Moe R.E., Ellis G.K., Livingstone R.B., Pelton J., et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys. 26:1993;23-35.
5. Buzdar A.U., Kan S.W., Smith T.L., Ames F., Singletary A., Strom E., et al. The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer. Cancer. 71:1993;3680-3684.
6. Calais G., Serin D., Fourquet A., Bosset J.F. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) vs sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. preliminary results: acute toxicity and treatment compliance. Breast Cancer Research and Treatment. 46:1997;31.
7. Clarke D.M., Le M.G., Sarrazin D., Lacombe M.J., Fontaine F., Travagli J.P., et al. Analysis of the local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of Institut Gustave Roussy. Int J Radiat Oncol Biol Phys. 11:1985;137-145.
8. Craig Henderson I., Allegra J.C., Woodcock T., Wolff S., Bryan S., Cartwright K., et al. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously untreated patients with metastatic breast cancer. J Clin Oncol. 7:1989;560-571.
9. Denham J., Hamilton C.S., Christie D., O'Brien M., Bonaventura A., Stewart J.F., et al. Simultaneous adjuvant radiation therapy and chemotherapy in high risk breast cancer. Toxicity and dose modification. Int J Radiat Oncol Biol Phys. 31:1995;305-313.
10. Dubey A., Recht A., Come S.E., Gelman R.S., Silver B., Harris J.R., et al. Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study. Int J Radiat Oncol Biol Phys. 45:1999;877-884.
11. Systemic treatment of early breast cancer by hormonal cytotoxic or immune therapy. One hundred thirthy-three randomized trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet. 339:1992;1-15. and 71-84.
12. Elmongy M., Stolier A., Linares L., Seiler M. Concurrent use of Taxol and radiation therapy for the adjuvant treatment of cancer of the breast. Breast Cancer Res Treat. 57:1999;48.
13. Faul C., Brufsky A., Gerszten K., Flickinger J., Kunschner A., Jacob H., et al. Concurrent sequencing of full-dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery. Eur J Cancer. 2003;763-768.
14. Fiets W.E., van Helvoirt R.P., Nortier J.W., van der Tweel I., Struikmans H. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. Eur J Cancer. 39:2003;1081-1088. a prospective, comparative, non-randomised study.
15. Fischer B., Redmond C., Wickherham D.L., Bowman D., Schipper H., Wolmark N., et al. Doxorubicin-containing regimens for the treatment of stage II breast cancer: The national surgical adjuvant breast and bowel project experience. J Clin Oncol. 7:1989;572-582.
16. Fischer B., Brown A.M., Dimitrov N.V., Poisson R., Redmond C., Margolese R., et al. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with six months of CMF in positive node breast cancer patients with tamoxifen non responsive tumors: results from the national surgical adjuvant breast and bowel project B15. J Clin Oncol. 8:1990;1483-1496.
17. Fountzilas G., Polichronis A., Genatas S., Vasilaros S., Kosmidis P., Klouvas G., et al. Cyclophosphamide + Methotrexate + Fluorouracil versus Cyclophosphamide + Mitoxantrone + Fluorouracil as adjuvant treatment in node positive breast cancer. Proceed Am Soc Clin Oncol. 13:1994;111.
18. Froud P.J., Mates D., Jackson S.H., Philips N., Andersen S., Jackson S.M., et al. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys. 46:2000;362-372.
19. Hanna Y.M., Baglan K.L., Stromberg J.S. Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy. Breast J. 8:2002;149-153.
20. Harstell W.F., Recine D.C., Griem K.L., Murthy A.K. Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer. 76:1995;2497-2503.
21. Hoogenraad W.J., Frasen J.H., Van Turnhout J.M. Enhanced toxicity of radiotherapy due to epirubicin containing adjuvant chemotherapy in breast carcinoma patients. Radiother Oncol. 24:(S42):1992;158.
22. Isaac N., Panzarella T., Lau A., Mayers C., Kirkbride P., Tannock I.F., et al. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen. Cancer. 95:2002;696-703.
23. Kimler B.F., Handerson S.D., Mansfield C.M., Svoboda D.J., Cheng C.C. Effect of Mitoxantrone and thoracic irradiation on long term survival. Cancer Research. 42:1982;2656-2659.
24. Leonard C.E., Wood M.E., Zhen B., Rankin J., Waitz D.A., Norton L., et al. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control. J Clin Oncol. 13:1995;296-315.
25. Markiewicz D.A., Schultz D.J., Haas J.A. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy. Int J Radiat Oncol Biol Phys. 35:1996;661-668.
26. Meek A.G., Park T.L., Weiss T.A., Bethune W.A. Effect of delayed radiation therapy on local control in breast conservation therapy. Radiology. 3:1996;615-619.
27. Misset J.L., Delgado M., Chollet P., Belpomme D., Fargeot P., Fumoleau P. Ten-years results of the french trial comparing adriamycin, vincristin, 5FU and cyclophosphamide to standard CMF as adjuvant therapy for node positive breast cancer. Proceed Am Soc Clin Oncol. 11:1992;41.
28. Nissen-Meyer R., Kjellgren K., Malmio K., Mansson B., Norin T. Surgical adjuvant chemotherapy results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer. 41:1978;2028-2038.
29. Nixon A.J., Recht A., Neuberg D., Connoly J.L., Schnitt S., Abner A., et al. The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy. Int J Radiat Oncol Biol Phys. 30:1994;17-21.
30. Novak R.F., Kharas C.H. Mitoxantrone propensity for free radical formation and lipid peroxydation. Implications for cardiotoxicity. Invest. New Drugs. 3:1985;95-99.
31. Overgaard M., Hansen P., Overgaard J., Rose C., Andersson M., Bach F., et al. Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy. New Engl. J Med. 337:1997;949-955.
32. Pouillart P., Follezou J.Y., Palangie T., Feuilhade F., George C., Richards E. Long-term results of a randomized trial comparing regimens of cyclophosphamide and fluorouracil with either mitoxantrone or doxorubicin in patients with advanced breast cancer. Eur J Cancer. 30:1994;716-717.
33. Ragaz J., Jackson S.M., Le N., Plenderleith I., Spinelli J., Basco V., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. New Engl. J Med. 337:1997;956-962.
34. Recht A., Come S.E., Henderson C., Gelman R., Silver B., Hayes D.F., et al. Sequencing of chemotherapy (CT) and radiotherapy (RT) following conservative surgery for patients with early-stage breast cancer: results of a randomized trial. New Engl J Med. 334:1996;1356-1361.
35. Robert J., Mornex F. Radiothérapie et chimiothérapie concomitantes des cancers. Aspects pharmacologiques. Bull Cancer Radiother. 80:1993;331-338.
36. Rosso K., Amoroso D., Bertilli G. Adjuvant chemotherapy in breast cancer: impact of individual dose intensity on treatment outcome. Third International Symposium Biology and Therapy of Breast Cancer Genova :1989;. A23.
37. Serin D., Aimard L., Kirscher S., Felix-Faure C. Chimiothérapie adjuvante FNC et radiothérapie concomitante dans les cancers du sein de stade II. Étude de faisabilité Bull Cancer. 80:1993;541.
38. Slotman B.J., Meyer W.M., Njo K.H., Karim A.B. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol. 30:1994;206-212.
39. Taghian A.G., Assaad S.I., Niemierko A., Kuter I., Younger J., Schoentaler R., et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst. 93:2001;1806-1811.
40. Conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? Int J Radiat Oncol Biol Phys. 40:1998;869-874.
41. Vujovic O., Perera F., Rashid D., Stitt L., Yu E., Voruganti S.M., et al. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? Int J Radiat Oncol Biol Phys. 40:(4):1998 Mar 1;869-874.
42. Wallgren A., Bernier J., Gelbre R.D., Goldhirsch A., Roncadin M., Joseph D., et al. Timing of radiotherapy and chemotherapy following breast-conservative surgery for patients with node-positive breast cancer. Int J Radiat Oncol Biol Phys. 35:1996;649-659.
43. Whelan T.J., Clarke R.M., Levine M.N., Willan A., McCulloch P., Lipa M., et al. The effect of delay in initiating radiotherapy post-lumpectomy on local breast recurrence. Int J Radiat Oncol Biol Phys. 36:(Number 1, Supplement):1996;280. (Abstract).
44. Winer E.P., Burstein H.J., Galper S. Prospective phase I evaluation of concurrent paclitaxel and breast radiation therapy following adjuvant doxorubicin/cyclophosphamide (AC) chemotherapy for stage II/III breast cancer [abstract]. Proc Am Soc Clin Oncol. 20:2001;39a.